lapatinib has been researched along with plumbagin in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (plumbagin) | Trials (plumbagin) | Recent Studies (post-2010) (plumbagin) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 537 | 0 | 346 |
| Protein | Taxonomy | lapatinib (IC50) | plumbagin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 2.77 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 2.46 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 6.3 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 3 | |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | 0.7 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 3.1 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 6.3 | |
| Histone acetyltransferase p300 | Homo sapiens (human) | 2 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 6.15 | |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | 0.06 | |
| 60 kDa chaperonin | Escherichia coli | 2.045 | |
| 10 kDa chaperonin | Escherichia coli | 2.045 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bratton, MR; Jones, FE; Klein Stevens, CL; Nguyen, TL; Sfondouris, ME; Sridhar, J; Townley, I | 1 |
1 other study(ies) available for lapatinib and plumbagin
| Article | Year |
|---|---|
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
Topics: Antibodies, Monoclonal, Humanized; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Structure; Quinones; Receptor, ErbB-2; Structure-Activity Relationship; Trastuzumab | 2014 |